Published in Mol Microbiol on March 01, 2000
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest (2001) 3.04
The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun (2003) 2.17
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol (2014) 1.40
Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog (2006) 1.36
Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog (2006) 1.34
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun (2006) 1.31
Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc Natl Acad Sci U S A (2005) 1.29
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Enhancer-binding proteins HrpR and HrpS interact to regulate hrp-encoded type III protein secretion in Pseudomonas syringae strains. J Bacteriol (2001) 1.19
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med (2009) 1.11
The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol (2009) 1.10
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun (2008) 1.09
Interactions between partner switcher orthologs BtrW and BtrV regulate type III secretion in Bordetella. J Bacteriol (2005) 1.08
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
The BvgAS signal transduction system regulates biofilm development in Bordetella. J Bacteriol (2005) 1.05
Transcriptional profiling of the iron starvation response in Bordetella pertussis provides new insights into siderophore utilization and virulence gene expression. J Bacteriol (2011) 1.02
Virulence factor secretion and translocation by Bordetella species. Curr Opin Microbiol (2009) 1.02
Suppression of NF-kappaB-mediated beta-defensin gene expression in the mammalian airway by the Bordetella type III secretion system. Cell Microbiol (2005) 1.00
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Control of biofilm formation and colonization in Vibrio fischeri: a role for partner switching? Environ Microbiol (2010) 0.96
Comparison of bipA alleles within and across Bordetella species. Infect Immun (2003) 0.94
Generating super-shedders: co-infection increases bacterial load and egg production of a gastrointestinal helminth. J R Soc Interface (2012) 0.93
Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection. Infect Immun (2005) 0.92
Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract. Infect Immun (2003) 0.91
Expression of a functional secreted YopN-TyeA hybrid protein in Yersinia pestis is the result of a +1 translational frameshift event. J Bacteriol (2004) 0.90
The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane. J Bacteriol (2004) 0.90
Constraint-based network model of pathogen-immune system interactions. J R Soc Interface (2008) 0.89
Bordetella bronchiseptica flagellin is a proinflammatory determinant for airway epithelial cells. Infect Immun (2005) 0.89
Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation. Infect Immun (2005) 0.88
Phenotypic modulation of the virulent Bvg phase is not required for pathogenesis and transmission of Bordetella bronchiseptica in swine. Infect Immun (2011) 0.88
Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol (2006) 0.86
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
Modulation of the NF-kappaB pathway by Bordetella pertussis filamentous hemagglutinin. PLoS One (2008) 0.84
In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity. FEMS Microbiol Lett (2007) 0.84
Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality. Infect Immun (2011) 0.83
The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine. Infect Immun (2013) 0.83
Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host. Antiinflamm Antiallergy Agents Med Chem (2009) 0.82
Toll-like receptor 4 limits transmission of Bordetella bronchiseptica. PLoS One (2014) 0.81
Transcriptional profiling of Bordetella pertussis reveals requirement of RNA chaperone Hfq for Type III secretion system functionality. RNA Biol (2015) 0.80
Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol (2012) 0.80
The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice. Infect Immun (2013) 0.77
Genome implosion elicits host-confinement in Alcaligenaceae: evidence from the comparative genomics of Tetrathiobacter kashmirensis, a pathogen in the making. PLoS One (2013) 0.77
Identification of a CO2 responsive regulon in Bordetella. PLoS One (2012) 0.77
Bordetella pertussis transmission. Pathog Dis (2015) 0.76
Characterization of the N-terminal domain of BteA: a Bordetella type III secreted cytotoxic effector. PLoS One (2013) 0.76
Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection. PLoS One (2015) 0.76
Differential regulation of type III secretion and virulence genes in Bordetella pertussis and Bordetella bronchiseptica by a secreted anti-σ factor. Proc Natl Acad Sci U S A (2016) 0.75
High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78
Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67
Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84
Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37
Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92
Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69
Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69
Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34
Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29
Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Early embryonic mortality in women. Fertil Steril (1982) 2.92
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Fetal loss after implantation. A prospective study. Lancet (1980) 2.73
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67
Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66
A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64
Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol (1989) 2.29
Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26
The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med (1998) 2.25
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07
A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol (1998) 1.99
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94
Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92
Effect of thymectomy in adult mice on immunological responsiveness. Nature (1965) 1.91
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature (1990) 1.87
The immune response of normal, irradiated and thymectomized mice to fowl immunoglobulin G as detected by a hemolytic plaque technique. Int Arch Allergy Appl Immunol (1971) 1.85
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells. Cell Immunol (1972) 1.78
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun (1999) 1.76
Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect Immun (1998) 1.74
Autogenous regulation of the Bordetella pertussis bvgABC operon. Proc Natl Acad Sci U S A (1990) 1.72
Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol (2006) 1.70
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica. Mol Microbiol (1996) 1.69
Interaction of thymus lymphocytes with histoincompatible cells. I. Quantitation of the proliferative response of thymus cells. Cell Immunol (1972) 1.68
The immunological responsiveness of germ-free mice thymectomized at birth. I. Antibody production and skin homograft rejection. Clin Exp Immunol (1967) 1.66
Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc Natl Acad Sci U S A (1994) 1.65
In vivo studies of DnaA binding to the origin of replication of Escherichia coli. EMBO J (1989) 1.60
Effect of recent antigen priming on adoptive immune responses. I. Specific unresponsiveness of cells from lymphoid organs of mice primed with heterologous erythrocytes. J Exp Med (1973) 1.58
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity (2001) 1.58
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
Cell to cell interaction in the immune response. V. Target cells for tolerance induction. J Exp Med (1970) 1.55
Thymus and the production of antibody-plaque-forming cells. Nature (1965) 1.54
Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J Exp Med (1993) 1.53
Mechanisms of Bordetella pathogenesis. Front Biosci (2001) 1.52
The relation between age and mean length of utterance in morphemes. J Speech Hear Res (1981) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
The thymus. Yesterday, today, and tomorrow. Lancet (1967) 1.50
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci U S A (1999) 1.49
Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells. Cell Immunol (1972) 1.49
Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol Microbiol (2001) 1.47
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47